We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current BDSX market cap is 148.81M. The company's latest EPS is USD -0.5379 and P/E is -2.83.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.61M | 9.06M | 11.87M | 13.49M | 14.67M |
| Operating Income | -13.89M | -16.37M | -10.93M | -7.17M | -6.87M |
| Net Income | -20.34M | -18.7M | -13.36M | -10.95M | -9.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 24.55M | 45.56M | 54.51M | 38.21M | 49.09M |
| Operating Income | -26.74M | -22.93M | -40.94M | -50.59M | -41.34M |
| Net Income | -30.73M | -31.35M | -43.16M | -65.45M | -52.15M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.91M | 80.79M | 77.62M | 86.79M | 99.1M |
| Total Liabilities | 72.3M | 76.24M | 84.62M | 88.23M | 94.52M |
| Total Equity | 20.61M | 4.55M | -6.99M | -1.45M | 4.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.63M | 121.07M | 76.1M | 92.91M | 99.1M |
| Total Liabilities | 76.21M | 79.9M | 56.37M | 72.3M | 94.52M |
| Total Equity | -228.54M | 41.17M | 19.73M | 20.61M | 4.58M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -44.97M | -7.69M | -6.75M | -10.59M | -22.87M |
| Investing | -3.53M | -7.71M | -14.18M | -20.06M | -23.06M |
| Financing | 58.88M | -2.42M | -4.75M | 7.4M | 29.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.73M | -21.37M | -28.22M | -44.97M | -22.87M |
| Investing | -1.87M | -2.93M | -2.55M | -3.53M | -23.06M |
| Financing | 22.97M | 81.13M | 1.26M | 58.88M | 29.13M |
| Market Cap | 148.81M |
| Price to Earnings Ratio | -2.83 |
| Price to Sales Ratio | 3 |
| Price to Cash Ratio | 5.61 |
| Price to Book Ratio | 32.17 |
| Dividend Yield | - |
| Shares Outstanding | 96.94M |
| Average Volume (1 week) | 133.58k |
| Average Volume (1 Month) | 84.62k |
| 52 Week Change | 5.14% |
| 52 Week High | 2.21 |
| 52 Week Low | 1.03 |
| Spread (Intraday) | 0.01 (0.65%) |
| Company Name | Biodesix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.biodesix.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
